4
Views
1
CrossRef citations to date
0
Altmetric
Gene Expression

Lipopolysaccharide-Unresponsive Mutant Pre-B-Cell Lines Blocked in NF-κB Activation

, , , , , , & show all
Pages 422-425 | Received 13 Jul 1989, Accepted 03 Oct 1989, Published online: 01 Apr 2023

Literature Cited

  • Atchison, M. L., and R. P. Perry 1988. Complementation between two lines lacking k enhancer activity: implications for the developmental control of immunoglobulin transcription. EMBO J. 1: 4213-4220.
  • Baeuerle, P., and D. Baltimore 1988. Activation of DNA- binding activity in an apparently cytoplasmic prescursor of the NF-κB transcription factor. Cell 53: 211-217.
  • Baeuerle, P., and D. Baltimore 1988. IκB: a specific inhibitor of the NF-κB transcription factor. Science 242: 540-546.
  • Briskin, M., M., Kuwabara, D., Sigman, and R. Wall 1988. Induction of k transcription by interferon-7 without activation of NF-κB. Science 242: 1036-1037.
  • Dignam, J. D., R. M., Lebovitz, and R. G. Roeder 1983. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 11: 1475-1489.
  • Giri, J. G., P. W., Kincade, and S. B. Mizel 1984. Interleukin 1-mediated induction of k light chain synthesis and surface immunoglobulin on pre-B cells. J. Immunol. 132: 223-228.
  • Gonazalez, G. A., K. K., Yamamoto, W. G., Fisher, D., Karr, P., Menzel, W., Biggs in, W. W., Vale, and M. R. Montminy 1989. A cluster of phosphorylation sites on the cyclic AMP-regulated nuclear factor CREB predicted by its sequence. Nature (London) 337: 749-752.
  • KeUey, D. E., C., Coleclough, and R. P. Perry 1982. Functional significance and evolutionary development of the 5′ terminal regions of immunoglobulin variable-region genes. Cell 29: 681-689.
  • Kincade, P. W. 1987. Experimental models for understanding B lymphocyte formation. Adv. Immunol. 41: 181-267.
  • Lee, G., L. R., Ellingsworth, S., Gillis, R., Wall, and P. W. Kincade 1987. β Transforming growth factors are potential regulators of B lymphocytes. J. Exp. Med. 166: 1290-1299.
  • Lenardo, M., J. W., Pierce, and D. Baltimore 1987. Protein binding sites in Ig gene enhancers determine transcriptional activity and inducibility. Science 236: 1573-1577.
  • Mains, P., and C. Sibley 1983. LPS-nonresponsive variants of mouse B cell lymphoma, 70Z/3: isolation and characterization. Somatic Cell Genet. 9: 690-720.
  • Paige, C. J., P. W., Kincade, and P. Ralph 1978. Murine B cell leukemia line with inducible surface immunoglobulin expression. J. Immunol. 121: 641-647.
  • Pierce, J. W., M., Lenardo, and D. Baltimore 1988. Oligonucleotide that binds nuclear factor NF-κB acts as a lymphoid- specific and inducible enhancer element. Proc. Natl. Acad. Sci. USA 85: 1482-1486.
  • Rosoff, P. M., L. F., Stein, and L. C. Cantley 1984. Phorbol esters induce differentiation in a pre-B-lymphocyte cell line by enhancing Na+/H+ exchange. J. Biol. Chem. 259: 7059-7060.
  • Sen, R., and D. Baltimore 1986. Multiple nuclear factors interact with the immunoglobulin enhancer sequences. Cell 46: 705-716.
  • Sen, R., and D. Baltimore 1986. Inducibility of k immunglobulin enhancer-binding protein NF-κB by a posttranslational mechanism. Cell 47: 921-928.
  • Shirakawa, F., M., Chedid, J., Suttles, B. A., PoUok, and S. B. Mizel 1989. Interleukin-1 and cyclic AMP induce k immunoglobulin light chain expression via activation of an NF-κB-like DNA binding protein. Mol. Cell. Biol. 9: 959-964.
  • Shirakawa, F., and S. B. Mizel 1989. In vitro activation and nuclear translocation of NF-κB catalyzed by cyclic AMP- dependent protein kinase and protein kinase C. Mol. Cell. Biol. 9: 2424-2430.
  • Wall, R., M., Briskin, C., Carter, H., Govan, A., Taylor, and P. Kincade 1986. A labile inhibitor blocks immunoglobulin k- light-chain-gene transcription in a pre-B leukemic cell line. Proc. Natl. Acad. Sci. USA 83: 295-298.
  • Weeks, R., and C. Sibley 1987. Molecular analysis of immunoglobulin expression in variants of murine B lymphoma, 70Z/3. Somatic Cell Mol. Genet. 13: 205-219.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.